Pages that link to "Q45743184"

The following pages link to Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B. (Q45743184):

Displaying 32 items.

• PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1 (Q24633837) (← links)
• In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil (Q28345952) (← links)
• The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance (Q28350136) (← links)
• Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus (Q28365198) (← links)
• Susceptibility testing. Viral pathogens. (Q30329370) (← links)
• Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo (Q32043207) (← links)
• Reverse transcriptase activity of hepatitis B virus polymerase in eukaryotic cell extracts in vitro. (Q33374547) (← links)
• Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies (Q33788626) (← links)
• Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro (Q34112556) (← links)
• Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation (Q34299035) (← links)
• Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection. (Q34363078) (← links)
• Diagnosis and management of pre-core mutant chronic hepatitis B. (Q34368364) (← links)
• Virus population dynamics, fitness variations and the control of viral disease: an update (Q34452529) (← links)
• Evolving therapies for the treatment of chronic hepatitis B virus infection (Q34519117) (← links)
• A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection (Q34716850) (← links)
• Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance (Q34756218) (← links)
• Hepatitis B virus resistance to antivirals: clinical implications and management. (Q35621690) (← links)
• Review article: Nucleoside analogues for the treatment of chronic hepatitis B. (Q35987869) (← links)
• Treatment of follicular non-Hodgkin's lymphoma (Q35989683) (← links)
• Mutations affecting the replication capacity of the hepatitis B virus (Q36515349) (← links)
• Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied? (Q37762114) (← links)
• Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis (Q39029942) (← links)
• Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model (Q39755479) (← links)
• The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. (Q40012022) (← links)
• Dynamics of hepatitis B virus resistance to lamivudine (Q41908360) (← links)
• Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1. (Q43792563) (← links)
• Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy. (Q44738460) (← links)
• Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients (Q45227673) (← links)
• Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist? (Q45409700) (← links)
• Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B. (Q46832056) (← links)
• New virologic tests and their application in management of chronic hepatitis B (Q46956460) (← links)
• The DNA-Chip technology as a new molecular tool for the detection of HBV mutants (Q51588168) (← links)